nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

Frese, Kristopher K

nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. [electronic resource] - Cancer discovery Mar 2012 - 260-269 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2159-8290

10.1158/2159-8290.CD-11-0242 doi


Albumins--administration & dosage
Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Carcinoma, Pancreatic Ductal--drug therapy
Cytidine Deaminase--metabolism
Deoxycytidine--administration & dosage
Disease Models, Animal
Drug Synergism
Mice
Paclitaxel--administration & dosage
Pancreatic Neoplasms--drug therapy
Gemcitabine